Few medicines have generated as much online chatter in such a short space of time as Foundayo. Since the MHRA authorised orforglipron on 10 August 2026, making the UK the first country in Europe to approve this GLP-1 weight loss tablet, social media, forums and word of mouth have filled in the gaps left by …
Starting any new medicine naturally raises questions, and Foundayo is no exception. As one of the first patients in Europe able to access this GLP-1 weight loss tablet, following its MHRA authorisation on 10 August 2026, it is entirely reasonable to want a clear picture of what side effects to expect before you begin. Headlines …
It has been a remarkable year for anyone paying attention to weight loss treatment in the UK. Twelve months ago, GLP-1 medicines meant one thing: a weekly injection. In 2026, that assumption has been turned on its head twice over, first with the arrival of the Wegovy pill in June, and then with the MHRA’s …
Leicester patients have not had to wait long to hear about the next big development in weight loss treatment. Foundayo, the brand name for orforglipron, was authorised by the Medicines and Healthcare products Regulatory Agency on 10 August 2026, making the UK the first country in Europe to approve this once-daily GLP-1 weight loss tablet. …
Sheffield has quietly become one of the busiest cities in Yorkshire for private weight loss treatment, and it did not take long for local patients to start asking about the latest development. Foundayo, the brand name for orforglipron, was authorised by the Medicines and Healthcare products Regulatory Agency on 10 August 2026, making the UK …
Manchester patients have been quick to notice the news. Foundayo, the brand name for orforglipron, was authorised by the Medicines and Healthcare products Regulatory Agency on 10 August 2026, making the UK the first country in Europe to approve this once-daily GLP-1 weight loss tablet. For a city that has embraced weight loss injections like …
Choosing a weight loss tablet used to mean one option in the UK: Orlistat. That has changed considerably in recent months, with the arrival of the Wegovy pill and now Foundayo, giving patients an oral choice for the first time between three genuinely different types of medicine. It is easy to see why this is …
The race towards oral weight loss medication has taken another significant turn, and patients across the UK are already asking what it means for them. Foundayo, the brand name for orforglipron, has just been approved in the United States as the first GLP-1 weight loss pill with no food or water restrictions, a genuine milestone …